A search for natural products produced in fermentation cultures of a strain of Phoma macrostoma led to the identification of tyrosol as the major metabolite produced by this organism. The addition of the amino acid tyrosine to growing fermentation cultures of P. macrostoma resulted in an increase in the production of tyrosol. It was subsequently determined that this strain of P. macrostoma was also capable of the biotransformation of other amino acids into similar alcohols.
There is a constant need to search for new natural products that have interesting biological properties. A well demonstrated source of biologically active natural products is the fermentation broth of filamentous fungi. As part of a research program aimed at examining the biosynthesis of biologically active natural products we have been screening various fungal strains in fermentation culture for the production of secondary metabolites. A report of the isolation of macrocidin A from a strain of Phoma macrostoma [1] led us to search a strain of this organism for the presence of secondary metabolites. We obtained a related strain of P. macrostoma (Montagne) from the Canadian Collection of Fungal Cultures (see ITS sequence in Supporting information) and examined the metabolite profile produced during fermentation in standard media. We determined that the major metabolite produced by this strain of P. macrostoma is the alcohol tyrosol [2-(4-hydroxyphenyl)ethanol].
Tyrosol is an important secondary metabolite that is common to many plant species, and is in fact a major constituent of olive oil [2a] . There is a fair amount of interest in the medicinal properties of tyrosol, as it has been suggested to have a significant cardioprotective role [2b] . In fact, it is the presence of tyrosol in olive oil that has been suggested to be responsible for part of the health benefits associated with the consumption of this oil [2c] . In addition, tyrosol has also been proposed as playing a role in the cardioprotection that results from consumption of moderate amounts of white wine [2d]. Although common in plants, production of tyrosol by filamentous fungi, such as P. macrostoma, is relatively rare. Only a few reports exist of the isolation of tyrosol from filamentous fungi [3a-3c] .
It has been previously demonstrated that tyrosol is produced by the yeast Saccharomyces cerevisiae when fed tyrosine [4] . In addition, it has been reported that various other yeast strains are capable of carrying out biotransformation of amino acids and converting them to substituted alcohols [5a] . For instance, it was reported that phenylalanine could be converted to the important aroma compound 2-phenylethanol in good yield. There is a commercial interest in the production of 2-phenylethanol [5b] and the pathways used by S. cerevisiae for value-added alcohol production has recently been reviewed [5c]. In light of this interest, we decided to investigate the biotransformation capabilities of P. macrostoma in fermentation culture. Spores of P. macrostoma were propagated on potato dextrose agar (PDA) for a period of two weeks until extensive sporulation had occurred. A plug of agar was excised from the mature plate using a sterile cork borer and used to inoculate 1 L cultures of potato dextrose broth (PDB). The organic (EtOAc) extract was examined for the presence of secondary metabolites by a combination of HPLC and NMR spectroscopy. In all fermentations a biological media control of PDB was incubated under identical conditions and in every case this flask remained clear of fungal growth. In our initial screening of the extracts we noticed in the 1 H NMR spectra peaks consistent with the presence of tyrosol. There appeared to be no other identifiable metabolite present in this extract. In both 1 H NMR and HPLC analysis of the extract from the media control flask the presence of tyrosol could not be detected. The presence of tyrosol in fermentation broth of P. macrostoma seemed to suggest that this metabolite might have been derived from the biotransformation of L-tyrosine, as had been demonstrated in yeasts [4] . It also seemed likely that P. macrostoma may also be capable of transforming other aromatic amino acids into alcohols homologous to tyrosol. We set out to test this theory with a series of biotransformation experiments, as described below.
Our initial biotransformation experiment focused on the effect of adding L-tyrosine to fermentation cultures of P. macrostoma. We found an increased yield of tyrosol in the fed fermentation extract (5.3 mg / L), as compared with the culture to which no L-tyrosine had been added (2.2 mg / L).
We then decided to examine the effect of adding Lphenylalanine to a culture of P. macrostoma by adding 1 g of this amino acid to a fermentation culture. Examination of the 1 H NMR spectrum of the neutral extract from the fed culture displayed peaks consistent with the presence of 2-phenylethanol. We found a yield of 3.6 mg / L (0.5 % molar conversion) of 2phenylethanol in the fed culture and could detect no trace of this metabolite in the extract from the control fermentation culture. There was no trace of any metabolites in the extract of the medium control flask. Our yields of 2-phenylethanol are low when compared with those achievable with yeast (S. cerevisiae) systems, where the conversions are above 50 % molar conversion. [6a] An additional biotransformation experiment was conducted to determine the effect of adding L-tryptophan to P. macrostoma cultures by feeding 1 g of L-tryptophan to a fermentation culture. We found a yield of ca. 12 mg / L of indole-3-ethanol in the fed culture (0.1 % molar yield) and could detect no trace of this metabolite in the extract from the control fermentation culture. There was no trace of any metabolites in the extract of the media control flask. In the biotransformation of both L-phenylalanine and L-tryptophan it was possible to detect a trace amount of tyrosol in the crude extract of the fermentation culture.
In order to confirm the identity of the isolated biotransformation products we prepared authentic standards by chemical synthesis [6b]. We employed LiAlH 4 reduction of the corresponding acetic acid derivative to provide an authentic sample of each alcohol. The 1 H NMR spectrum and HPLC retention time were for each of the biotransformation products identical to the standards prepared in our laboratory.
We have identified a strain of P. macrostoma that is capable of transforming aromatic amino acids into alcohol derivatives. We have characterized the biotransformation products by comparison of NMR spectroscopic data with authentic samples synthesized in our laboratory. The ability of P. macrostoma to carry out this biotransformation may represent a way to produce value-added alcohols from inexpensive amino acid starting materials. This is particularly attractive, as these transformations would be a challenge to achieve synthetically in a single step from amino acids. Additionally, production of these alcohols by P. macrostoma cultures would represent a natural transformation, something that is of interest in the food additive industries [6c]. Although the biotransformation yields that we report here are quite low, work is currently under way to make improvements in this area. In addition we are also looking to expand the scope of this biotransformation by examining other amino acid substrates for P. macrostoma.
Experimental
General: All laboratory chemicals and biological media were purchased from Sigma-Aldrich chemical company (Oakville, Ontario); solvents were HPLC grade and were used without further purification. Flash column chromatography (FCC) was carried out on Silica gel 60 mesh (200 Å particle size). Sterilization of all microbiological media and equipment was achieved at 121°C and 15 psi for 25 minutes. NMR spectra were obtained using a Bruker Avance spectrometer operating at 300 MHz. HPLC data were collected on a Waters Alliance 2695 separations module using a Waters 2996 photodiode array detector. The column employed was a Waters μBondapack C 18 (15-20 μm, 125 Å) 3.9 x 300 mm column employing a gradient of Milli-Q water (0.75% trifluoroacetic acid) and methanol operating at a flow rate of 1 mL / min. The gradient started at 20% MeOH and after 10 mins at this composition ramped to 100% MeOH over 10 mins. After an additional 20 mins at 100 % MeOH, the original 20% MeOH was restored over 10 mins and held at this composition for 10 mins before the end of the run. Total run time for gradient was 60 mins.
Propagation of fungal cultures:
Agar plugs with live spores of Phoma macrostoma were obtained from the Canadian Collection of Fungal Cultures (strain ID 119, see ITS sequence in Supporting information). These plugs were placed spore-side down on freshly prepared potato dextrose agar (PDA) containing 100 μg / mL of streptomycin sulfate. The agar containing Petri dishes (14 cm) were incubated at 30°C for 2 weeks in ambient light until the culture had sporulated.
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Fermentation cultures for metabolite screening: Five 1 L Erlenmeyer flasks each with 500 mL of sterile potato dextrose broth (PDB) were inoculated with a plug of P. macrostoma spore-covered PDA. A media control flask of 100 mL of PDB (in a 250 mL flask) was also prepared. These flasks were then incubated on a platform shaker at 30°C and 200 rpm for 7 days. The fermentation cultures were harvested by removing the mycelia using gravity filtration through cheesecloth. The combined aqueous broth (2.5 L) was then extracted with ethyl acetate (2 x 1L) . The combined organic extracts were dried (Na 2 SO 4 ) filtered and evaporated under reduced pressure and this residue set aside as the neutral extract. The combined organic layers were dried (Na 2 SO 4 ), filtered and evaporated, and this residue set aside as the acidic extract. The extracts were then subjected to analysis by HPLC, TLC and 1 H NMR spectroscopy.
Isolation of tyrosol:
The crude residue (110 mg) from the neutral extraction above was applied to a silica gel column and fractionated by FCC using a gradient of CH 2 Cl 2 and MeOH (0.5 -10% MeOH). Similar fractions were combined according to TLC analysis and evaporated under reduced pressure to leave a residue that was then analyzed by TLC and 1 H NMR spectroscopy. The residues containing tyrosol were then subjected to further purification by preparative TLC (20 x 20 x 0.25 cm plate; 10% MeOH in CH 2 Cl 2 ) to yield 5.7 mg of pure tyrosol (ca. 2.2 mg / L). The spectroscopic data matched those observed for a standard prepared sample (Supporting Information).
Tyrosine biotransformation:
Two 2 L Erlenmeyer flasks were prepared with 1 L of sterile PDB in each. A media control flask (1 L) containing 500 mL of sterile PDB was also prepared. Each fermentation flask was inoculated with a plug of P. macrostoma spore-covered PDA. The medium control flask was not inoculated. The flasks were placed on a platform shaker operating at 30°C and 200 rpm for 2 days in order to establish growth. At this point, to each 1 L fermentation culture was added 100 mg of solid L-tyrosine every 12 h for 5 days (total 1 g / L of L-tyrosine added). After the final addition of L-tyrosine, the cultures were left on the shaker for an additional 2 days. The media control flask had 50 mg of solid L-tyrosine added at each interval, but was otherwise treated identically. This medium control culture remained free of fungal growth. The mature fermentation cultures were then extracted in a manner identical to that described above for the screening of metabolites. The control flask was also extracted in a similar fashion. The crude residue (33.7 mg) from the neutral extract of the fed culture was subjected to preparative TLC (20 x 20 x 0.25 cm plate; 10% MeOH in CH 2 Cl 2 ) to yield 10.6 mg of tyrosol (ca. 5.3 mg / L).
Phenylalanine biotransformation:
Two 2 L Erlenmeyer flasks were prepared with 1 L of sterile PDB in each. A control flask (250 mL) containing 100 mL of sterile PDB was also prepared. Each culture flask was inoculated with a plug of agar from a Petri dish covered in P. macrostoma spores. The media control flask was not inoculated. The flasks were placed on a platform shaker operating at 30°C and 200 rpm for 2 days in order to establish growth. To one of the 1 L fermentation cultures of P. macrostoma was added 100 mg of solid L-phenylalanine every 12 h for 5 days (total 1 g / L of L-phenylalanine added). After the final addition of L-phenylalanine, the cultures were incubated on the shaker for an additional 2 days. The other 1 L fermentation culture had no amino acid added to it but was incubated for an identical amount of time as the fed culture to serve as a control fermentation culture. The media control flask had 10 mg of solid L-phenylalanine added at each interval, but was otherwise treated identically. This medium control flask remained free of fungal growth. The fermentation cultures were each extracted in a manner identical to that described above for the screening of metabolites. The medium control flask was also extracted in a similar fashion and the residue examined in a manner similar to that for the fermentation culture. The crude residue (19.6 mg) from the extraction of the control fermentation culture was examined by 1 H NMR spectroscopy and HPLC, and the presence of phenylethanol could not be detected. The crude residue (26.3 mg) from the extraction of the L-phenylalanine fed fermentation culture was subjected to preparative TLC to yield 2-phenylethanol (ca. 3.6 mg/L; 0.5% molar conversion).
Tryptophan biotransformation:
The biotransformation experiment involving L-tryptophan was conducted in a manner identical to that described for L-phenylalanine except that 100 mg of solid L-tryptophan was added at each feeding. The medium control culture remained free of growth. The crude residue (53.4 mg) from the neutral extract of the control fermentation culture was examined by 1 H NMR spectroscopy and HPLC, and the presence of indole-3-ethanol could not be detected. The crude neutral extract (95.1 mg) of the L-tryptophan fed culture was subjected to FCC to yield 13.7 mg of nearly pure indole-3-ethanol (ca. 12 mg / L; 0.1 % molar conversion). A portion (5 mg) of this material was further purified by preparative TLC (10 % MeOH in CH 2 Cl 2 ) to give 1 mg of pure indole-3-ethanol.
Preparation of synthetic standards:
The reduction of the acetic acid derivatives followed a previously reported procedure [6b]. A suspension of 222.0 mg (6 mmol, 3 eq) of LiAlH 4 in 10 mL of anhydrous THF in a dry 25 mL RBF was prepared and cooled to 0°C in ice. To this suspension was slowly added a solution of 2 mmol of acetic acid derivative in 10 mL of anhydrous THF. After the addition was completed, the suspension was heated, with stirring, at reflux overnight. After cooling to room temperature in an ice bath, 10 mL of ice cold water was added to eliminate the excess hydride. The pH of the mixture was adjusted to ca. 4 by dropwise addition of concentrated HCl. The aqueous layer was extracted with CH 2 Cl 2 (2 x 15 mL) and the combined organic layers washed with water (3 x 10 mL), followed by brine (1 x 10 mL). The organic layer was filtered and dried using sodium sulfate (Na 2 SO 4 ) and conc under vacuum. The residue was purified by FCC eluting with a gradient of 0% -10% MeOH in CH 2 Cl 2 .
Supplementary data:
A supplementary data file containing the ITS sequence for Phoma macrostoma, as well as 1 H NMR spectra of biotransformation products and characterization data (both 1 H NMR and 13 C NMR spectra) of synthetic standards is included, free of charge, on line.
